Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 28% ± 10% | |
type I pneumocyte | 8 studies | 28% ± 10% | |
epithelial cell | 8 studies | 36% ± 15% | |
respiratory goblet cell | 7 studies | 32% ± 8% | |
club cell | 6 studies | 35% ± 7% | |
squamous epithelial cell | 4 studies | 46% ± 19% | |
secretory cell | 4 studies | 35% ± 9% | |
type II pneumocyte | 4 studies | 23% ± 5% | |
plasma cell | 3 studies | 41% ± 34% | |
basal cell | 3 studies | 51% ± 31% | |
pancreatic ductal cell | 3 studies | 38% ± 14% | |
alveolar macrophage | 3 studies | 25% ± 3% | |
renal principal cell | 3 studies | 38% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 6 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 883.55 | 326 / 328 | 88% | 16.96 | 157 / 178 |
kidney | 100% | 1576.40 | 89 / 89 | 84% | 29.62 | 759 / 901 |
lung | 98% | 1240.96 | 569 / 578 | 73% | 17.50 | 846 / 1155 |
stomach | 69% | 397.84 | 247 / 359 | 94% | 25.94 | 270 / 286 |
breast | 75% | 826.71 | 342 / 459 | 76% | 10.94 | 851 / 1118 |
intestine | 48% | 417.98 | 459 / 966 | 95% | 24.48 | 501 / 527 |
thymus | 73% | 192.19 | 478 / 653 | 58% | 6.49 | 348 / 605 |
esophagus | 39% | 843.95 | 569 / 1445 | 79% | 22.48 | 144 / 183 |
bladder | 48% | 294.52 | 10 / 21 | 70% | 13.64 | 351 / 504 |
spleen | 88% | 260.19 | 211 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 80% | 562.07 | 207 / 258 | 1% | 0.10 | 3 / 230 |
uterus | 15% | 60.48 | 25 / 170 | 64% | 9.26 | 292 / 459 |
prostate | 69% | 358.65 | 169 / 245 | 9% | 0.59 | 45 / 502 |
skin | 76% | 736.96 | 1367 / 1809 | 1% | 0.08 | 6 / 472 |
ovary | 2% | 5.04 | 4 / 180 | 67% | 9.00 | 289 / 430 |
tonsil | 0% | 0 | 0 / 0 | 56% | 7.30 | 25 / 45 |
adipose | 23% | 71.59 | 280 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 1249.79 | 178 / 929 | 0% | 0 | 0 / 0 |
liver | 3% | 5.86 | 7 / 226 | 8% | 1.19 | 34 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.86 | 3 / 29 |
blood vessel | 6% | 20.19 | 86 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.54 | 2 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0.12 | 1 / 2642 | 0% | 0.01 | 1 / 705 |
heart | 0% | 0.28 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0008083 | Molecular function | growth factor activity |
Gene name | MACC1 |
Protein name | Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) |
Synonyms | |
Description | FUNCTION: Acts as a transcription activator for MET and as a key regulator of HGF-MET signaling. Promotes cell motility, proliferation and hepatocyte growth factor (HGF)-dependent scattering in vitro and tumor growth and metastasis in vivo. . |
Accessions | Q6ZN28 ENST00000332878.8 ENST00000589011.1 ENST00000400331.10 |